A1040: Cancer Antigen 125 (CA 125)

Cancer Antigen 125 (CA 125) - Ovarian Cancer Tumor Marker

Cancer Antigen 125 (CA 125) is a well-established ovarian cancer-associated biomarker widely used in oncology research and in vitro diagnostic (IVD) development. This product is derived from cell culture supernatant and processed under rigorous quality standards for consistency and reliability.

CA 125 is essential for tracking disease progression, evaluating therapeutic response, and validating assay sensitivity in ovarian and related cancers.

Specifications

• Source: Cell Culture Supernatant
• Buffer & pH: PBS Buffer, pH 7.4 ± 0.1
• Preservative: 0.1% Sodium Azide
• Filtration: 0.2 µm filtered
• Storage: -20°C or colder
• Protein Quantitation: ~117,310 U/mL (cobas CA 125 Assay)*
• Purity Ratio: ~4,597 U/mL/OD280*

*Specific lot values may vary

Key Features

• Tested non-reactive for HIV 1/2, HBsAg, HCV, HIV-1 (NAT), and HCV (NAT) by current FDA methods
• Sourced from USDA-inspected U.S. abattoirs
• 0.2 µm filtered and formulated in PBS with sodium azide preservative
• For research use or manufacturing of non-injectable products only

Applications

• Development and calibration of immunoassays (ELISA, CLIA, LFA)
• Ovarian cancer biomarker research and monitoring studies
• Quality control materials for diagnostic kit production
• Multiplex cancer antigen panel validation